Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma (Q54628349)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 4, 2010

edit

Language	Label	Description	Also known as
English	Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma	scientific article published on December 4, 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

title

Combined Positron Emission Tomography/Computed Tomography in Sunitinib Therapy Assessment of Patients with Metastatic Renal Cell Carcinoma (English)

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

main subject

tomography

1 reference

based on heuristic

inferred from title

author

Sophie D. Fosså

series ordinal

5

object named as

S D Fosså

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

author name string

M. E. Revheim

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21134733

retrieved

19 November 2024

A. K. Winge-Main

series ordinal

2

ORCID iD

0000-0002-7399-2990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21134733

retrieved

19 November 2024

G. Hagen

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21134733

retrieved

19 November 2024

J. G. Fjeld

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21134733

retrieved

19 November 2024

W. Lilleby

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21134733

retrieved

19 November 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21134733

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21134733

retrieved

19 November 2024

publication date

4 December 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

full work available at URL

https://api.elsevier.com/content/article/PII:S0936655510004528?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

https://api.elsevier.com/content/article/PII:S0936655510004528?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

published in

Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

page(s)

339-343

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

cites work

Chemotherapy in metastatic renal cell cancer

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Targeted agents for the treatment of advanced renal cell carcinoma

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

RECIST revisited: a review of validation studies on tumour assessment

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Quantitative assessment of tumor metabolism using FDG-PET imaging

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

The lessons of GIST--PET and PET/CT: a new paradigm for imaging

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

18F-FDG PET/CT imaging for an early assessment of response to sunitinib in metastatic renal carcinoma: preliminary study

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Response evaluation of gastrointestinal stromal tumors

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Diagnosis and staging of pancreatic tumors

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/J.CLON.2010.11.006

reference URL

https://api.crossref.org/works/10.1016/J.CLON.2010.11.006

retrieved

19 November 2024

Identifiers

DOI

10.1016/J.CLON.2010.11.006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

PubMed publication ID

21134733

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21134733

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21134733

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54628349&oldid=2276955806"